Concepedia

Lorenza Di Guardo

LD

Statistics

Publications

32

Citations

1.9K

H-Index

19

Active since

2010

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Istituto Oncologico Veneto

University of Siena

Lorenza Di Guardo is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2010–2023

32

Publications

32

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Veronica Huber, Viviana Vallacchi, Viktor Fleming et al. · Journal of Clinical Investigation · 2018 · 256 citations · Full text

Medicine, Immunology, Oncology +17

Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

Alice Indini, Lorenza Di Guardo, Carolina Cimminiello et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 199 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Journal of Translational Medicine · 2014 · 163 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Michele Del Vecchio, Lorenza Di Guardo, Paolo A. Ascierto et al. · European Journal of Cancer · 2013 · 157 citations · Full text

Medicine, Oncology, Pharmacology +12

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

Michele Maio, Riccardo Danielli, Vanna Chiarion‐Sileni et al. · Annals of Oncology · 2013 · 141 citations

Medicine, Oncology, Pharmacotherapy +12

1–5 of 32